Gender Differences in Outcome During Antihypertensive Therapy in Relation to Regression of Electrocardiographic Left Ventricular Hypertrophy: The LIFE Study

被引：0

作者：

Okin, Peter M. ^{[1
]}

Gerdts, Eva ^{[2
,3
]}

Hille, Darcy A. ^{[4
]}

Kjeldsen, Sverre E. ^{[5
]}

Edelman, Jonathan M. ^{[6
]}

Dahlof, Bjorn ^{[7
]}

Devereux, Richard B. ^{[1
]}

机构：

[1] Weill Cornell Med Coll, New York, NY USA

[2] Univ Bergen, Bergen, Norway

[3] Haukeland Hosp, N-5021 Bergen, Norway

[4] Merck Rsch Labs, West Point, PA USA

[5] Univ Oslo, Ulleval Hosp, Oslo, Norway

[6] Merck & Co Inc, Whitehouse Stn, NJ USA

[7] Sahlgrens Univ Hosp, Gothenburg, Sweden

来源：

CIRCULATION | 2009年 / 120卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S1111 / S1111

页数：1

共 50 条

[1] Gender Differences in Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy
Okin, Peter M.
Gerdts, Eva
Kjeldsen, Sverre E.
Julius, Stevo
Edelman, Jonathan M.
Dahlof, Bjorn
Devereux, Richard B.
[J]. HYPERTENSION, 2008, 52 (01) : 100 - 106
[2] Gender Differences in the Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy
Agabiti-Rosei, Enrico
Salvetti, Massimo
[J]. HYPERTENSION, 2008, 52 (01) : 59 - 60
[3] Gender Differences in Regression of Electrocardiographic Left Ventricular Hypertrophy during Antihypertensive Therapy
Rosenkranz, Alexander R.
[J]. JOURNAL FUR HYPERTONIE, 2009, 13 (03): : 35 - 36
[4] Gender differences in regression of electrocardiographic left ventricular hypertrophy in response to anti hypertensive therapy: The LIFE study
Okin, PM
Devereux, RB
Jam, S
Kjeldsen, SE
Julius, S
Dahlof, B
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 230A - 230A
[5] Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death -: The LIFE study
Wachtell, Kristian
Okin, Peter M.
Olsen, Michael H.
Dahlof, Bjorn
Devereux, Richard B.
Ibsen, Hans
Kjeldsen, Sverre E.
Lindholm, Lars H.
Nieminen, Markku S.
Thygesen, Kristian
[J]. CIRCULATION, 2007, 116 (07) : 700 - 705
[6] Continued regression of electrocardiographic left ventricular hypertrophy after two years of antihypertensive therapy: The LIFE study
Okin, PM
Liu, JE
Jern, S
Julius, S
Kjeldsen, SE
Dahlof, B
[J]. CIRCULATION, 2001, 104 (17) : 575 - 575
[7] Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events: The LIFE study
Okin, PM
Jern, S
Kjeldsen, SE
Julius, S
Nieminen, MS
Snapinn, S
Harris, KE
Aurup, P
Edelman, JM
Dahlof, B
[J]. CIRCULATION, 2002, 106 (19) : 573 - 573
[8] Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy -: The Losartan Intervention for Endpoint (LIFE) Reduction in Hypertension Study
Okin, PM
Devereux, RB
Gerdts, E
Snapinn, SM
Harris, KE
Jern, S
Kjeldsen, SE
Julius, S
Edelman, JM
Lindholm, LH
Dahlöf, B
[J]. CIRCULATION, 2006, 113 (12) : 1588 - 1596
[9] Regression of echocardiographic left ventricular hypertrophy in relation to resolution versus persistence of electrocardiographic strain after one year of antihypertensive therapy: The LIFE study
Okin, PM
Devereux, RB
Palmieri, V
Liu, JE
Wachtell, K
Nieminen, MS
Jem, S
Oikarinen, L
Viitasalo, M
Kjeldsen, SE
Julius, S
Dahlof, B
LIFE Study Investigators
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 236A - 236A
[10] Hypertensive patients with diabetes have less regression of electrocardiographic left ventricular hypertrophy in response to antihypertensive therapy: The LIFE study
Okin, PM
Devereux, RB
Jern, S
Kjeldsen, SE
Julius, S
Dahlof, B
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 319A - 320A

← 1 2 3 4 5 →